V.F. DOLGUSHINA, N.K. VEREINA, Yu.V. FARTUNINA, T.V.

NADVIKOVA

South Ural State Medical University, Chelyabinsk

  Contact:

Fartunina Yu.V. ― postgraduate student of the Department of Obstetrics and Gynecology

Address: 64 Vorovskogo Str., 454092, Chelyabinsk, Russian Federation, tel. +7-906-866-42-06, e-mail: fluffy13@mail.ru

Objective. To study the features of anamnesis, course of gestation and delivery outcomes in women with and without coinciding diagnoses of antenatal fetal growth restriction (FGR) and postnatal intrauterine growth restriction (IUGR).

Material and methods. We examined 153 pregnant women with FGR revealed by ultrasound photometry. Hypotrophy was confirmed after birth in 88 newborns and not confirmed in 65 newborns.

Results. Pregnant women with FGR and hypotrophy of newborns had the elevated risk of chromosomal abnormalities, severe preeclampsia in the second trimester, oligohydramnios and hemodynamic disorders in “mother-placenta-fetus” system. In cases of not coinciding diagnoses, pregnant women more often had “great obstetrical syndromes” in anamnesis; in most cases in this group they had prevention of preeclampsia and venous thromboembolism.

Conclusion. Both in cases with and without coinciding diagnoses of FGR and IUGR, the examined patients showed no clinical-anamnestic features, but in coinciding diagnoses the pregnancy was more often characterized by complicated course, pre-mature delivery and disadvantageous prenatal outcome.

Key words: pregnancy, fetal growth restriction, placental insufficiency, preeclampsia.

REFERENCES

1. Sharma D., Shastri S., Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr, 2016, no. 10, rr. 67-83. doi:10.4137/CMPed.S40070
2. Priante E, Verlato G, Giordano G, et al. Intrauterine Growth Restriction: New Insight from the Metabolomic Approach. Metabolites, 2019, no. 9, rr. 267-280. doi:10.3390/metabo9110267
3. Nardozza L.M., Caetano A.C., Zamarian A.C. et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet, 2017, no. 295, rr. 1061–1077. doi:10.1007/s00404-017-4341-9
4. Tang L., He G., Liu X., Xu W. Progress in the understanding of the etiology and predictability of fetal growth restriction. Reproduction, 2017, no.153, R. 227–240. doi:10.1530/REP-16-0287
5. Ganichkina M.B., Mantrova D.A., Kan N.E., Tyutyunnik V.L., Khachaturyan A.A., Ziganshina M.M. Management of pregnancy with fetal growth retardation. Akusherstvo i ginekologiya, 2017, no.10, pp. 5-11 (in Russ.).
6. Kesavan K., Devaskar S.U. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatr Clin North Am, 2019, no. 66, rr. 403-423. doi:10.1016/j.pcl.2018.12.009
7. Leite D.F.B., Cecatti J.G. Fetal Growth Restriction Prediction: How to Move beyond. The Scientific World Journal, 2019, no. 3, rr. 1-8. doi:10.1155/2019/1519048
8. McCowan L.M., Figueras F., Anderson N.H. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol., 2018, no.218, rr. 855-868. doi:10.1016/j.ajog.2017.12.004
9. Monier I., Blondel B., Ego A., Kaminiski M., Goffinet F., Zeitlin J. Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study. BJOG, 2015, no. 122, rr. 518-527. doi:10.1111/1471-0528.13148
10. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol, 2013, no. 208, rr. 290-296. doi:10.1016/j.ajog.2013.02.007
11. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol., 2019, no.133, rr. 97-109. doi:10.1097/AOG.0000000000003070
12. Inácio Q.A.S., Araujo Júnior E., Nardozza L.M.M., Petrini C.G., Campos V.P., Peixoto A.B. Perinatal Outcomes of Fetuses with Early Growth Restriction, Late Growth Restriction, Small for Gestational Age, and Adequate for Gestational Age. Rev Bras Ginecol Obstet, 2019, no. 41, rr. 688-696. doi:10.1055/s-0039-1697987
13. Gabbay-Benziv R., Aviram A., Hadar E. et al. Pregnancy outcome after false diagnosis of fetal growth restriction. J Matern Fetal Neonatal Med, 2017, no.30, rr. 1916-1919. doi:10.1080/14767058.2016.1232383
14. Hadlock F.P., Harrist R.B., Carpenter R.J., Deter R.L., Park S.K. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology, 1984, no.150, rr. 535-540. doi: 10.1148/radiology.150.2.6691115
15. Savel’eva G.M., Sukhikh G.T., Serov V.N., Radzinskiy V.E. Akusherstvo: nats. ruk. 2-e izd., pererab. i dop. [Obstetrics: nat. hands. 2nd ed., Revised. and add.]. Moscow: GEOTAR-Media, 2015. Pp. 243-245.
16. Vikhareva O.N., Voevodin S.M., Demidov V.N., Mikhaylov A.V., Emel’yanenko E.S., Yusupov K.F. Dopplerometricheskoe issledovanie vo vremya beremennosti [Dopplerometric examination during pregnancy]. Klinicheskie protokoly. Moscow: Nauchnyy tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, 2015. 8 p.
17. Anesteziya i intensivnaya terapiya u patsientok, poluchayushchaya antikoagulyanty dlya profilaktiki i lecheniya venoznykh tromboembolicheskikh oslozhneniy v akusherstve. Klinicheskie rekomendatsii (Protokol lecheniya), 2016 [Anesthesia and intensive care in patients receiving anticoagulants for the prevention and treatment of venous thromboembolic complications in obstetrics. Clinical recommendations (treatment protocol), 2016], available at: http://www.arfpoint.ru/wp-content/uploads/2018/06/tromboprofilaktika_kr.pdf (accessed on: 20.03.2020)
18. Gipertenzivnye rasstroystva vo vremya beremennosti, v rodakh i poslerodovom periode. Preeklampsiya. Eklampsiya. Klinicheskie rekomendatsii (Protokol lecheniya), 2016 [Hypertensive disorders during pregnancy, childbirth and the postpartum period. Preeclampsia Eclampsia. Clinical recommendations (treatment protocol). 2016], available at: http://www.rokb.ru/sites/default/files/pictures/gipertenzivnye_rasstroystva_vo_vremya_beremennosti_v_rodah_i_poslerodovom_periode._preeklampsiya._eklampsiya.pdf (accessed on: 20.03.2020)
19. 2013 GROWTH CHART, available at: https://www.ucalgary.ca/fenton/2013chart (accessed on: 20.03.2020)
20. Frank G.A. et al. Pravila provedeniya patologo-anatomicheskikh issledovaniy platsenty Klass XV i XVI MKB-10. Klinicheskie rekomendatsii. Rossiyskoe obshchestvo patologoanatomov [Rules for conducting pathological and anatomical studies of the placenta Class XV and XVI ICD-10. Clinical recommendations. Russian Society of Pathologists]. Moscow, 2017. 74 p.
21. Tay J., Masini G., McEniery C.M. et al. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function. Am J Obstet Gynecol, 2019, no. 220, rr. 961-968. doi:10.1016/j.ajog.2018.09.017
22. Loussert L., Vidal F., Parant O., Hamdi S.M., Vayssiere C., Guerby P. Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn, 2020, no. 10, rr. 1-30. doi:10.1002/pd.5645
23. Groom K.M., David A.L. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol, 2018, no. 218, rr. 829-840. doi:10.1016/j.ajog.2017.11.565

24. Lafalla O., Esteban L.M., Lou A.C. et al. Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis. J Matern Fetal Neonatal Med, 2019, rr. 1-11. doi:10.1080/14767058.2019.1611764
25. Mazarico E., Molinet-Coll C., Martinez-Portilla R.J., Figueras F. Heparin therapy in placental insufficiency: Systematic review and meta-analysis. Acta Obstet Gynecol Scand, 2020, no. 99, rr. 167–174. doi:10.1111/aogs.13730
26. Sabra S., Gratacós E., Gómez Roig M.D. Smoking-Induced Changes in the Maternal Immune, Endocrine, and Metabolic Pathways and Their Impact on Fetal Growth: A Topical Review. Fetal Diagn Ther, 2017, no. 41, rr. 241-250. doi:10.1159/000457123
27. Wilkerson R.G., Ogunbodede A.C. Hypertensive Disorders of Pregnancy. Emerg Med Clin North Am, 2019, no. 37, rr. 301-316. doi:10.1016/j.emc.2019.01.008
28. Dudley N.J. A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol, 2005, no. 25, rr. 80-89. doi:10.1002/uog.1751
29. Lappen J.R., Myers S.A. The systematic error in the estimation of fetal weight and the underestimation of fetal growth restriction. Am J Obstet Gynecol, 2017, no. 216, rr. 477-483. doi:10.1016/j.ajog.2017.02.013